NCT05173961

Brief Summary

This clinical trial determines how well the oncpatient mobile application work in assisting patients undergoing radiation treatment. Radiation therapy can be complex. The technology, daily treatments, and possible side effects can be confusing to prevent and manage. Traditional radiation patient education includes a large amount of information, including details of treatment logistics, side effect prevention, and management. However, this information is not always readily accessible or memorable through the long course of therapy, and critical details can be missed. Oncpatient is a mobile application intended to be a more convenient and accessible form of patient education and guidance that is readily available to help patients and their caretakers navigate through radiation treatment.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
1mo left

Started Jun 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
Jun 2022Jun 2026

First Submitted

Initial submission to the registry

December 27, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 30, 2021

Completed
6 months until next milestone

Study Start

First participant enrolled

June 29, 2022

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2026

Last Updated

January 5, 2026

Status Verified

December 1, 2025

Enrollment Period

4 years

First QC Date

December 27, 2021

Last Update Submit

December 31, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Completion rate

    The percent of patients who indicate in the survey that they were able to download the application and use it at least once during radiation will be defined as the completion rate.

    Up to 1 year

Secondary Outcomes (3)

  • Patient opinions on the usability and helpfulness of the mobile application in helping them through radiation treatments

    Up to 1 year

  • Satisfaction with the mobile application and radiation treatment

    Up to 1 year

  • Opinions on existing or new features for the mobile application to be given to future patients

    Up to 1 year

Study Arms (1)

Supportive Care (oncpatient application, survey)

EXPERIMENTAL

Patients use the oncpatient mobile application over the course of radiation therapy. Patients also complete a survey on the final day of radiation treatment.

Other: Internet-Based InterventionOther: Survey Administration

Interventions

Use oncpatient mobile application

Supportive Care (oncpatient application, survey)

Complete survey

Supportive Care (oncpatient application, survey)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 and older.
  • Can read and speak English and provide informed consent.
  • Diagnosed with cancer, any stage, any disease site.
  • Must be consented to undergo a course of radiotherapy, starting within one month. No limits on duration of radiation apply. Patients must be consented prior to initiating radiotherapy, however.
  • Has regular access to a mobile device.

You may not qualify if:

  • Less than 18 years old.
  • Non-English speaking.
  • Inability to operate a mobile device.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

City of Hope Medical Center

Duarte, California, 91010, United States

Location

MeSH Terms

Conditions

Hematologic Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsHematologic DiseasesHemic and Lymphatic Diseases

Study Officials

  • Colton Ladbury

    City of Hope Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 27, 2021

First Posted

December 30, 2021

Study Start

June 29, 2022

Primary Completion (Estimated)

June 15, 2026

Study Completion (Estimated)

June 15, 2026

Last Updated

January 5, 2026

Record last verified: 2025-12

Locations